4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Volume 36 Issue 6
Nov.  2022
Turn off MathJax
Article Contents
Abstract
Acknowledgments
References
Related Articles
Supplements
Evgenii Dmitrievich Kryl'skii, Darya Andreevna Sinitsyna, Tatyana Nikolaevna Popova, Khidmet Safarovich Shikhaliev, Svetlana Mikhajlovna Medvedeva, Larisa Vladimirovna Matasova, Valentina Olegovna Mittova. The new antioxidant 1-benzoyl-6-hydroxy-2,2,4-trimethyl-1,2-dihydroquinoline has a protective effect against carbon tetrachloride-induced hepatic injury in rats[J]. The Journal of Biomedical Research, 2022, 36(6): 423-434. DOI: 10.7555/JBR.36.20220098
Citation: Evgenii Dmitrievich Kryl'skii, Darya Andreevna Sinitsyna, Tatyana Nikolaevna Popova, Khidmet Safarovich Shikhaliev, Svetlana Mikhajlovna Medvedeva, Larisa Vladimirovna Matasova, Valentina Olegovna Mittova. The new antioxidant 1-benzoyl-6-hydroxy-2,2,4-trimethyl-1,2-dihydroquinoline has a protective effect against carbon tetrachloride-induced hepatic injury in rats[J]. The Journal of Biomedical Research, 2022, 36(6): 423-434. DOI: 10.7555/JBR.36.20220098
shu

The new antioxidant 1-benzoyl-6-hydroxy-2,2,4-trimethyl-1,2-dihydroquinoline has a protective effect against carbon tetrachloride-induced hepatic injury in rats

  • 1.

    Department of Medical Biochemistry and Microbiology, Voronezh State University, Voronezh, Voronezh region 394018, Russia

  • 2.

    Department of Organic Chemistry, Voronezh State University, Voronezh, Voronezh region 394018, Russia

  • 3.

    Department of Clinical Laboratory Diagnostics, Voronezh State Medical University named after N.N. Burdenko, Voronezh, Voronezh region 394036, Russia

More Information
  • Corresponding author:

    Evgenii Dmitrievich Kryl'skii, Department of Medical Biochemistry and Microbiology, Voronezh State University, Universitetskaya sq. 1, Voronezh, Voronezh region 394018, Russia. Tel: +7-473-2281160 ext. 1111, E-mail: evgenij.krylsky@yandex.ru

  • Received Date: April 29, 2022
  • Revised Date: June 29, 2022
  • Accepted Date: July 05, 2022
  • Available Online: July 27, 2022
    Graphical Abstract
    • Abstract
  • Liver diseases with the central pathogenetic mechanism of oxidative stress are one of the main causes of mortality worldwide. Therefore, dihydroquinoline derivatives, which are precursors of hepatoprotectors and have antioxidant activity, are of interest. We have previously found that some compounds in this class have the ability to normalize redox homeostasis under experimental conditions. Here, we initially analyzed the hepatoprotective potential of the dihydroquinoline derivative 1-benzoyl-6-hydroxy-2,2,4-trimethyl-1,2-dihydroquinoline (BHDQ) for carbon tetrachloride (CCl4)-induced liver injury in rats. Results suggested that BHDQ normalized the alanine aminotransferase, aspartate aminotransferase, and gamma-glutamyl transpeptidase in serum. We also observed an improvement in liver tissue morphology related to BHDQ. Animals with CCl4-induced liver injuries treated with BHDQ had less oxidative stress compared to animals with CCl4-induced liver injury. BHDQ promoted activation changes in superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, and glutathione transferase on control values in animals with CCl4-induced liver injury. BHDQ also activated gene transcription in Sod1 and Gpx1 via nuclear factor erythroid 2-related factor 2 and forkhead box protein O1 factors. Therefore, the compound of concern has a hepatoprotective effect by inhibiting the development of necrotic processes in the liver tissue, through antioxidation.
    • FullText(HTML)

  • This work was supported by the Russian Foundation for Basic Research (Grant No. 20-04-00526 А).

    CLC number: R965, Document code: A

    The authors reported no conflict of interests.

    • References (27)
  • [1]
    Wang R, Tang R, Li B, et al. Gut microbiome, liver immunology, and liver diseases[J]. Cell Mol Immunol, 2021, 18(1): 4–17. doi: 10.1038/s41423-020-00592-6
    [2]
    Lee YS, Cho IJ, Kim JW, et al. Hepatoprotective effects of blue honeysuckle on CCl4-induced acute liver damaged mice[J]. Food Sci Nutr, 2019, 7(1): 322–338. doi: 10.1002/fsn3.893
    [3]
    Saijou E, Enomoto Y, Matsuda M, et al. Neutrophils alleviate fibrosis in the CCl4-induced mouse chronic liver injury model[J]. Hepatol Commun, 2018, 2(6): 703–717. doi: 10.1002/hep4.1178
    [4]
    Dutta S, Chakraborty AK, Dey P, et al. Amelioration of CCl4 induced liver injury in swiss albino mice by antioxidant rich leaf extract of Croton bonplandianus Baill[J]. PLoS One, 2018, 13(4): e0196411. doi: 10.1371/journal.pone.0196411
    [5]
    Mortezaee K, Khanlarkhani N. Melatonin application in targeting oxidative-induced liver injuries: a review[J]. J Cell Physiol, 2018, 233(5): 4015–4032. doi: 10.1002/jcp.26209
    [6]
    Di Costanzo A, Angelico R. Formulation strategies for enhancing the bioavailability of silymarin: the state of the art[J]. Molecules, 2019, 24(11): 2155. doi: 10.3390/molecules24112155
    [7]
    Tereshchenko OG, Nikolskaya ED, Zhunina OA, et al. Formulation of perspective hepatoprotector polymeric forms based on silybin and ursodeoxycholic acid[J]. Russ Chem Bull, 2018, 67(12): 2290–2296. doi: 10.1007/s11172-018-2372-4
    [8]
    Muriel P, Rivera-Espinoza Y. Beneficial drugs for liver diseases[J]. J Appl Toxicol, 2008, 28(2): 93–103. doi: 10.1002/jat.1310
    [9]
    Yu Y, Cai J, She Z, et al. Insights into the epidemiology, pathogenesis, and therapeutics of nonalcoholic fatty liver diseases[J]. Adv Sci (Weinh), 2019, 6(4): 1801585. doi: 10.1002/advs.201801585
    [10]
    Iskusnykh IY, Kryl'skii ED, Brazhnikova DA, et al. Novel antioxidant, deethylated ethoxyquin, protects against carbon tetrachloride induced hepatotoxicity in rats by inhibiting NLRP3 inflammasome activation and apoptosis[J]. Antioxidants (Basel), 2021, 10(1): 122. doi: 10.3390/antiox10010122
    [11]
    Kryl'skii ED, Chupandina EE, Popova TN, et al. 1-benzoyl-6-hydroxy-2,2,4-trimethyl-1,2-dihydroquinoline exerts a neuroprotective effect and normalises redox homeostasis in a rat model of cerebral ischemia/reperfusion[J]. Metab Brain Dis, 2022, 37(4): 1271–1282. doi: 10.1007/s11011-022-00928-3
    [12]
    Onyibe PN, Edo GI, Nwosu LC, et al. Effects of vernonia amygdalina fractionate on glutathione reductase and glutathione-S-transferase on alloxan induced diabetes wistar rat[J]. Biocatal Agric Biotechnol, 2021, 36: 102118. doi: 10.1016/j.bcab.2021.102118
    [13]
    Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis[J]. Hepatology, 1981, 1(5): 431–435. doi: 10.1002/hep.1840010511
    [14]
    Piskarev IM, Trofimova SV, Burkhina OE, et al. Investigation of the level of free-radical processes in substrates and biological samples using induced chemiluminescence[J]. Biophysics, 2015, 60(3): 400–408. doi: 10.1134/S0006350915030148
    [15]
    Guilbault GG. Handbook of enzymatic methods of analysis[M]. New York: Marcel Dekker, 1976: 752.
    [16]
    Rao UM. Source of superoxide anion radical in aerobic mixtures consisting of NADH, 5-methylphenazinium methyl sulfate and nitroblue tetrazolium chloride[J]. Free Radical Biol Med, 1989, 7(5): 513–519. doi: 10.1016/0891-5849(89)90027-0
    [17]
    Góth L. A simple method for determination of serum catalase activity and revision of reference range[J]. Clin Chim Acta, 1991, 196(2–3): 143–151. doi: 10.1016/0009-8981(91)90067-m
    [18]
    Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase[J]. J Lab Clin Med, 1967, 70(1): 158–169. https://www.translationalres.com/article/0022-2143(67)90076-5/pdf
    [19]
    Zanetti G. Rabbit liver glutathione reductase. Purification and properties[J]. Arch Biochem Biophys, 1979, 198(1): 241–246. doi: 10.1016/0003-9861(79)90415-6
    [20]
    Warholm M, Guthenberg C, von Bahr C, et al. Glutathione transferases from human liver[J]. Methods Enzymol, 1985, 113: 499–504. doi: 10.1016/s0076-6879(85)13065-x
    [21]
    Błaszczyk A, Augustyniak A, Skolimowski J. Ethoxyquin: an antioxidant used in animal feed[J]. Int J Food Sci, 2013, 2013: 585931. doi: 10.1155/2013/585931
    [22]
    Jin C, Li B, Lin S, et al. Mechanism of the inhibitory effects of Eucommia ulmoides oliv. cortex extracts (EUCE) in the CCl4-induced acute liver lipid accumulation in rats[J]. Int J Endocrinol, 2013, 2013: 751854. doi: 10.1155/2013/751854
    [23]
    Popov SS, Anufrieva EI, Kryl'skii ED, et al. The effect of methylethylpiridinol addition to the therapy on the level of pigment epithelium-derived factor and oxidative status in patients with diabetic nephropathy: randomized controlled open-label clinical study[J]. J Diabetes Metab Disord, 2021, 20(1): 709–717. doi: 10.1007/s40200-021-00802-6
    [24]
    Zhuang Y, Wu H, Wang X, et al. Resveratrol attenuates oxidative stress-induced intestinal barrier injury through PI3K/Akt-mediated Nrf2 signaling pathway[J]. Oxid Med Cell Longev, 2019, 2019: 7591840. doi: 10.1155/2019/7591840
    [25]
    Xing Y, Li A, Yang Y, et al. The regulation of FOXO1 and its role in disease progression[J]. Life Sci, 2018, 193: 124–131. doi: 10.1016/j.lfs.2017.11.030
    [26]
    Miao W, Hu L, Kandouz M, et al. A cell-based system to identify and characterize the molecular mechanism of drug-metabolizing enzyme (DME) modulators[J]. Biochem Pharmacol, 2004, 67(10): 1897–1905. doi: 10.1016/j.bcp.2004.02.009
    [27]
    Xu G, Han X, Yuan G, et al. Screening for the protective effect target of deproteinized extract of calf blood and its mechanisms in mice with CCl4-induced acute liver injury[J]. PLoS One, 2017, 12(7): e0180899. doi: 10.1371/journal.pone.0180899
    • Related Articles

  • Related Articles

    [1]Xingxing Sun, Jun Wang, Qing Yan, Weizhu Ju, Fengxiang Zhang, Gang Yang, Kai Gu, Hailei Liu, Zidun wang, Xiaohong Jiang, Mingfang Li, Di Xu, Yi Xu, Hongwu Chen, Minglong Chen. Epicardial adipose tissue around the superior vena cava: A single center study of factors related to atrial fibrillation[J]. The Journal of Biomedical Research, 2022, 36(6): 401-408. DOI: 10.7555/JBR.36.20220047
    [2]Ling Chen, Ting Ma, Liang Wang, Lixin Wang, Minmin Li, Rong Zhu. Unilateral pleural effusion secondary to Takayasu arteritis: a case report and literature review[J]. The Journal of Biomedical Research, 2022, 36(2): 141-144. DOI: 10.7555/JBR.36.20210190
    [3]Xiaodong Chen, Minglong Chen, Yingying Wang, Bing Yang, Weizhu Ju, Fengxiang Zhang, Kejiang Cao. Assessment of atrial electromechanical interval using echocardiography after catheter ablation in patients with persistent atrial fibrillation[J]. The Journal of Biomedical Research, 2016, 30(6): 483-489. DOI: 10.7555/JBR.30.20150164
    [4]Yan Zhu, Meining Yu, Luyao Ma, Hai Xu, Fanghong Rose Li. Choriocarcinoma-associated pulmonary thromboembolism and pulmonary hypertension: a case report[J]. The Journal of Biomedical Research, 2016, 30(3): 243-247. DOI: 10.7555/JBR.30.20140062
    [5]Di Zhao, Ze-Mu Wang, Lian-Sheng Wang. Prevention of atrial fibrillation with renin-angiotensin system inhibitors on essential hypertensive patients: a meta-analysis of randomized controlled trials[J]. The Journal of Biomedical Research, 2015, 29(6): 475-485. DOI: 10.7555/JBR.29.20140149
    [6]Wei Qin, Liming Wang, Xin Chen, Peisheng Liu, Rui Wang. Left ventricular myxoma: a case report[J]. The Journal of Biomedical Research, 2014, 28(6): 506-508. DOI: 10.7555/JBR.28.20120124
    [7]Thomas M. Munger, Li-Qun Wu, Win K. Shen. Atrial fibrillation[J]. The Journal of Biomedical Research, 2014, 28(1): 1-17. DOI: 10.7555/JBR.28.20130191
    [8]Tongfu Yu, Mei Yuan, Qingbo Zhang, Haibing Shi, Dehang Wang. Evaluation of computed tomography obstruction index in guiding therapeutic decisions and monitoring percutanous catheter fragmentation in massive pulmonary embolism[J]. The Journal of Biomedical Research, 2011, 25(6): 431-437. DOI: 10.1016/S1674-8301(11)60057-2
    [9]Hailong Cao, Yanhu Wu, Jinfu Zhu, Yijiang Chen. Familial cardiac myxoma with multifocal recurrences: a case report and review of the literature[J]. The Journal of Biomedical Research, 2011, 25(5): 368-372. DOI: 10.1016/S1674-8301(11)60049-3
    [10]Jian Wang, Lei Xue, Hailong Cao, Fei Cui, Ting Dai, Yijiang Chen. TLR2 was overexpressed independent of IL-6 in patients with valvular atrial fibrillation[J]. The Journal of Biomedical Research, 2011, 25(3): 178-184. DOI: 10.1016/S1674-8301(11)60023-7
    • Supplements (1)

  • Other Related Supplements

Catalog

    Figures(7)  /  Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1008) PDF downloads (79) Cited by()
    Related

    ©2023 by the Editorial Department of the Journals of Nanjing Medical University. All rights reserved.   苏ICP备05071376号-5

    Supported by: Beijing Renhe Information Technology Co., Ltd. E-mail: info@rhhz.net  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return